LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.93 Cr | ₹-4.16 Cr | ₹-0.04 Cr | ₹-36 Cr | ₹-9.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of LASA SUPERGENERICS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.93 Cr |
Mar2023 | ₹-4.16 Cr |
Mar2022 | ₹-0.04 Cr |
Mar2021 | ₹-36 Cr |
Mar2020 | ₹-9.85 Cr |
How is Cash Flow from Financing Activities of LASA SUPERGENERICS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.93 Cr | Negative | |
Mar2023 | ₹-4.16 Cr | Negative | |
Mar2022 | ₹-0.04 Cr | Negative | |
Mar2021 | ₹-36 Cr | Negative | |
Mar2020 | ₹-9.85 Cr | - |
Compare Cash Flow from Financing Activities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹54.4 Cr | -4% | 10.8% | -52.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -4% |
10.8% |
-52.5% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses